Report Categories
View AllRecent Articles
View All
TNGX Tango Therapeutics reports narrower Q4 2025 loss than analyst estimates shares fall nearly two percent in todays trading
Amgen Inc AMGN Q1 2026 Earnings Robust Growth Pipeline Offsets Legacy Product Pressures
EPR Properties EPR Stock Is It Reversing Q4 2025 EPS Exceeds Expectations
The recurring revenue story behind Biglari BH Biglari posts 2337 EPS no analyst estimates yet